Former Wisconsin Rep. Mike Gallagher joined 'America's Newsroom' to discuss Trump's tariff threat against China and his ...
Eli Lilly & Co (LLY – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Mohit ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Eli Lilly And Co (NYSE:LLY) shares are trading higher Tuesday after the Biden-Harris Administration proposed a new rule to ...
Eli Lilly and Company chief corporate brand officer Lina Polimeni described the new format as a “big evolution” in the company’s marketing, shifting its focus to the Lilly brand, its patients and an ...
Stock futures declined Tuesday after President-elect Donald Trump said soon after he takes office he would enact a 25% tariff ...
The Health Resources and Services Administration has “invoked the nuclear option of removal from not only the 340B program ...
LLY's recent sell-off presents a buying opportunity for savvy investors, with strong growth potential in the GLP-1 market ...
The Converge platform validated as many as 83% of its treatment targets in disease models, a higher success rate than usual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback